196 related articles for article (PubMed ID: 24491089)
21. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
22. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
23. Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy.
Haque M; Das JK; Xiong X; Song J
Curr Diab Rep; 2019 Aug; 19(10):89. PubMed ID: 31471667
[TBL] [Abstract][Full Text] [Related]
24. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
25. Exposure to DDT metabolite p,p'-DDE increases autoimmune type 1 diabetes incidence in NOD mouse model.
Cetkovic-Cvrlje M; Olson M; Schindler B; Gong HK
J Immunotoxicol; 2016; 13(1):108-18. PubMed ID: 25721050
[TBL] [Abstract][Full Text] [Related]
26. Re-establishing immune tolerance in type 1 diabetes via regulatory T cells.
Gregori S; Battaglia M; Roncarolo MG
Novartis Found Symp; 2008; 292():174-83; discussion 183-6, 202-3. PubMed ID: 19203099
[TBL] [Abstract][Full Text] [Related]
27. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R
Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048
[TBL] [Abstract][Full Text] [Related]
28. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
29. Tolerance induction and reversal of diabetes in mice transplanted with human embryonic stem cell-derived pancreatic endoderm.
Szot GL; Yadav M; Lang J; Kroon E; Kerr J; Kadoya K; Brandon EP; Baetge EE; Bour-Jordan H; Bluestone JA
Cell Stem Cell; 2015 Feb; 16(2):148-57. PubMed ID: 25533131
[TBL] [Abstract][Full Text] [Related]
30. Tolerance to islet autoantigens in type 1 diabetes.
Bach JF; Chatenoud L
Annu Rev Immunol; 2001; 19():131-61. PubMed ID: 11244033
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune Diabetes: An Overview of Experimental Models and Novel Therapeutics.
You S; Chatenoud L
Methods Mol Biol; 2016; 1371():117-42. PubMed ID: 26530798
[TBL] [Abstract][Full Text] [Related]
32. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.
Tang Q; Henriksen KJ; Bi M; Finger EB; Szot G; Ye J; Masteller EL; McDevitt H; Bonyhadi M; Bluestone JA
J Exp Med; 2004 Jun; 199(11):1455-65. PubMed ID: 15184499
[TBL] [Abstract][Full Text] [Related]
33. Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis.
Yaochite JN; Caliari-Oliveira C; Davanso MR; Carlos D; Malmegrim KC; Cardoso CR; Ramalho LN; Palma PV; da Silva JS; Cunha FQ; Covas DT; Voltarelli JC
Immunobiology; 2013 Mar; 218(3):338-52. PubMed ID: 22704522
[TBL] [Abstract][Full Text] [Related]
34. Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.
Dáňová K; Grohová A; Strnadová P; Funda DP; Šumník Z; Lebl J; Cinek O; Průhová Š; Koloušková S; Obermannová B; Petruželková L; Šedivá A; Fundová P; Buschard K; Špíšek R; Palová-Jelínková L
J Immunol; 2017 Jan; 198(2):729-740. PubMed ID: 27927966
[TBL] [Abstract][Full Text] [Related]
35. Emerging Therapeutic Strategies to Restore Regulatory T Cell Control of Islet Autoimmunity in Type 1 Diabetes.
Volfson-Sedletsky V; Jones A; Hernandez-Escalante J; Dooms H
Front Immunol; 2021; 12():635767. PubMed ID: 33815387
[TBL] [Abstract][Full Text] [Related]
36. Is antigen specificity of autoreactive T cells the key to islet entry?
Penaranda C; Bluestone JA
Immunity; 2009 Oct; 31(4):534-6. PubMed ID: 19833083
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
38. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
Zhao Y; Lin B; Dingeldein M; Guo C; Hwang D; Holterman MJ
Transl Res; 2010 May; 155(5):211-6. PubMed ID: 20403575
[TBL] [Abstract][Full Text] [Related]
39. On the Role IL-4/IL-13 Heteroreceptor Plays in Regulation of Type 1 Diabetes.
Ukah TK; Cattin-Roy AN; Chen W; Miller MM; Barik S; Zaghouani H
J Immunol; 2017 Aug; 199(3):894-902. PubMed ID: 28646042
[TBL] [Abstract][Full Text] [Related]
40. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
